ES2075219T3 - Metodos y composiciones para curar ulceras. - Google Patents

Metodos y composiciones para curar ulceras.

Info

Publication number
ES2075219T3
ES2075219T3 ES90914339T ES90914339T ES2075219T3 ES 2075219 T3 ES2075219 T3 ES 2075219T3 ES 90914339 T ES90914339 T ES 90914339T ES 90914339 T ES90914339 T ES 90914339T ES 2075219 T3 ES2075219 T3 ES 2075219T3
Authority
ES
Spain
Prior art keywords
histidyl
warm
stomach
blooded animals
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90914339T
Other languages
English (en)
Inventor
Loren R Pickart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procyte Corp
Original Assignee
Procyte Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procyte Corp filed Critical Procyte Corp
Application granted granted Critical
Publication of ES2075219T3 publication Critical patent/ES2075219T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

SE PRESENTAN UNA VARIEDAD DE COMPOSICIONES ADECUADAS PARA UTILIZARLAS CON METODOS PARA (A) REDUCIR LA FORMACION DE ULCERAS ESTOMACALES EN ANIMALES DE SANGRE CALIENTE, (B) REDUCIR LA SECRECION DE ACIDO ESTOMACAL EN ANIMALES DE SANGRE CALIENTE, (C) AUMENTAR LA SECRECION DE LA MUCOSA CITOPROTECTORA EN EL ESTOMAGO EN ANIMALES DE SANGRE CALIENTE Y (D) CICATRIZAR ULCERAS INTESTINALES O ESTOMACALES ESTABLECIDAS EN ANIMALES DE SANGRE CALIENTE. LAS COMPOSICIONES INCLUYEN GLICIL-L-HISTIDIL-L-LISINA, LLISIL-L-HISTIDIL-GLICINA, L-LISIL-L-HISTIDIL-GLICINA: COBRE (II), GLICIL-LHISTIDIL-L-LISINA: COBRE (2) Y DERIVADOS DE LAS MISMAS.
ES90914339T 1989-08-30 1990-08-28 Metodos y composiciones para curar ulceras. Expired - Lifetime ES2075219T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/401,312 US5023237A (en) 1989-08-30 1989-08-30 Methods and compositions for healing ulcers

Publications (1)

Publication Number Publication Date
ES2075219T3 true ES2075219T3 (es) 1995-10-01

Family

ID=23587222

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90914339T Expired - Lifetime ES2075219T3 (es) 1989-08-30 1990-08-28 Metodos y composiciones para curar ulceras.

Country Status (11)

Country Link
US (1) US5023237A (es)
EP (1) EP0489860B1 (es)
JP (1) JPH05500221A (es)
KR (1) KR920703627A (es)
AT (1) ATE125820T1 (es)
AU (1) AU648517B2 (es)
CA (1) CA2065416A1 (es)
DE (1) DE69021386T2 (es)
DK (1) DK0489860T3 (es)
ES (1) ES2075219T3 (es)
WO (1) WO1991003488A1 (es)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5120831A (en) * 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
DK0486622T3 (da) * 1989-08-09 1999-07-19 Rhomed Inc Direkte radiomærkning af antistoffer og andre proteiner med technetium eller rhenium
US5443816A (en) * 1990-08-08 1995-08-22 Rhomed Incorporated Peptide-metal ion pharmaceutical preparation and method
US5145838A (en) * 1989-08-30 1992-09-08 Procyte Corporation Methods and compositions for healing ulcers
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en) 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5643549A (en) * 1992-02-20 1997-07-01 Rhomed Incorporated Leukostimulatory agent for in vivo leukocyte tagging
US5847007A (en) * 1993-05-13 1998-12-08 Neorx Corporation Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
US5382431A (en) * 1992-09-29 1995-01-17 Skin Biology, Inc. Tissue protective and regenerative compositions
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
EP0755256A4 (en) * 1994-03-28 1997-09-03 Skin Biology Inc STARCH-METAL COMPLEXES FOR SKIN AND HAIR
JPH07316192A (ja) * 1994-05-27 1995-12-05 Hoechst Japan Ltd Ｌ−リシル−グリシル−ｌ−ヒスチジンおよびこれを含有する創傷治療剤
US5891418A (en) * 1995-06-07 1999-04-06 Rhomed Incorporated Peptide-metal ion pharmaceutical constructs and applications
US6331285B1 (en) 1996-06-05 2001-12-18 Palatin Technologies, Inc. Structurally determined cyclic metallo-constructs and applications
US5698184A (en) * 1996-08-23 1997-12-16 Skin Biology, Inc. Compositions and methods for skin tanning and protection
US5888522A (en) * 1996-08-23 1999-03-30 Skin Biology, Inc. Tissue protective and regenerative compositions
US6117911A (en) * 1997-04-11 2000-09-12 Neorx Corporation Compounds and therapies for the prevention of vascular and non-vascular pathologies
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
CN1390231A (zh) 1999-10-01 2003-01-08 Dmi生物科学公司 金属－结合性化合物及其用途
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US20030130185A1 (en) * 2000-09-29 2003-07-10 David Bar-Or Metal-binding compounds and uses therefor
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7385025B2 (en) * 2000-12-19 2008-06-10 Palatin Technologies, Inc. Metallopeptide compounds
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method
WO2003030926A1 (en) * 2001-10-05 2003-04-17 Procyte Corporation Stable solutions of peptide copper complexes and cosmetic and pharmaceutical formulations produced therefrom
KR20050059003A (ko) * 2002-07-02 2005-06-17 프로사이트 코포레이션 펩티드 구리 착화합물 및 연조직 충전제를 함유하는조성물
US20040142853A1 (en) * 2002-11-07 2004-07-22 Procyte Corporation Stimulation of hair growth by compositions containing peptide copper complexes and minoxidil
US20040138103A1 (en) * 2002-11-07 2004-07-15 Procyte Corporation Compositions containing peptide copper complexes and metalloproteinase inhibitors and methods related thereto
US7128923B2 (en) * 2003-03-31 2006-10-31 Procyte Corporation Preserved and stable compositions containing peptide copper complexes and method related thereto
US6927205B2 (en) * 2003-04-28 2005-08-09 Procyte Corporation Compositions and methods for treatment of psoriasis
JP2007528356A (ja) * 2003-04-30 2007-10-11 ペプトロン カンパニー リミテッド ペプチドが結合したビタミンｃ誘導体、その製造方法およびそれを含む組成物
US6927206B2 (en) * 2003-06-06 2005-08-09 Procyte Corporation Compositions and methods for treatment of rosacea
WO2005097061A1 (en) * 2004-04-01 2005-10-20 Procyte Corporation Encapsulated peptide copper complexes and compositions and methods related thereto
US20060052287A1 (en) * 2004-08-18 2006-03-09 Procyte Corporation Polyethylene glycol - peptide copper complexes and compositions and methods related thereto
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
KR101324578B1 (ko) 2006-02-03 2013-11-01 제이알 켐, 엘엘씨 구리 및 아연 조성물을 사용하는 노화 방지 치료법
KR100691540B1 (ko) 2006-06-22 2007-03-12 주식회사 펩트론 펩타이드가 결합된 안정화된 비타민 ｃ 유도체, 이의제조방법 및 이를 함유하는 조성물
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US11471497B1 (en) 2019-03-13 2022-10-18 David Gordon Bermudes Copper chelation therapeutics

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3194732A (en) * 1960-10-03 1965-07-13 Neuhauser Irene Assisting healing of skin-denuded areas on the body with dried non-fibrous egg-shellmembrane products and compositions therefor
US3558770A (en) * 1967-09-01 1971-01-26 Kraftco Corp Wound treating composition employing an enzyme modified casein
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
US3767784A (en) * 1970-12-01 1973-10-23 S Gluck Composition for the protection and treatment of injured body tissue and method of utilizing the same
US3832338A (en) * 1972-03-23 1974-08-27 Diagnostic Data Inc Orgotein production using a buffer solution containing divalent metal salts
US3758682A (en) * 1972-03-23 1973-09-11 Diagnostics Data Inc Pharmaceutical compositions comprising orgotein and their use
US4022888A (en) * 1975-09-09 1977-05-10 Diagnostic Data, Inc. Esterified orgotein
DE2700043C2 (de) * 1977-01-03 1983-12-08 Thera Gesellschaft für Patentverwertung mbH, 8036 Herrsching Mittel zur Verbesserung der Durchblutung und Wundheilung
US4167945A (en) * 1977-01-31 1979-09-18 Gottlieb Sheldon K Method for enhancing the healing of grafted tissue
US4287184A (en) * 1977-11-23 1981-09-01 The Massachusetts General Hospital Process for healing wounds
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
US4440788A (en) * 1980-05-13 1984-04-03 Mitsubishi Chemical Industries, Limited Cysteine derivatives
US4461724A (en) * 1981-10-28 1984-07-24 Nippon Zoki Pharmaceutical Co., Ltd. Peptide compounds, a process for manufacturing them, pharmaceutical compositions containing them, and methods for treating ulcer and thrombus with them
HU193289B (en) * 1984-06-19 1987-09-28 Universal Vegyipari Szoevetkez Cosmetical composition for treating hair and nail containing blood plasma concentrate as active agent
US4937230A (en) * 1985-01-24 1990-06-26 Procyte Corporation Method of healing wounds in horses
US4760051A (en) * 1985-01-24 1988-07-26 Pickart Loren R Use of GHL-Cu as a wound-healing and anti-inflammatory agent
US4584284A (en) * 1985-01-31 1986-04-22 Ortho Pharmaceutical Corporation Bursopoietin
US4767753A (en) * 1985-02-08 1988-08-30 Procyte Corporation Methods and compositions for preventing ulcers
US4877770A (en) * 1985-02-08 1989-10-31 Procyte Corporation Chemical derivatives of GHL-Cu
US4810693A (en) * 1985-02-08 1989-03-07 Procyte Corporation Method for inducing biological coverings in wounds
US4665054A (en) * 1985-02-08 1987-05-12 Bioheal, Inc. Chemical derivatives of GHL-Cu

Also Published As

Publication number Publication date
US5023237A (en) 1991-06-11
EP0489860B1 (en) 1995-08-02
DK0489860T3 (da) 1995-12-11
DE69021386T2 (de) 1996-01-25
AU648517B2 (en) 1994-04-28
JPH05500221A (ja) 1993-01-21
WO1991003488A1 (en) 1991-03-21
KR920703627A (ko) 1992-12-18
AU6429490A (en) 1991-04-08
EP0489860A1 (en) 1992-06-17
DE69021386D1 (de) 1995-09-07
CA2065416A1 (en) 1991-03-01
ATE125820T1 (de) 1995-08-15

Similar Documents

Publication Publication Date Title
ES2075219T3 (es) Metodos y composiciones para curar ulceras.
MX9203471A (es) Hormona foliculo estimulante urinaria.
GR3005768T3 (es)
NO884135D0 (no) Vannopploeselig cellulosederivat, fremgangsmaate for dets fremstilling og anvendelse derav.
FR2600524B1 (fr) Oesophage artificiel.
DE3781163D1 (de) Manschette zum befestigen kuenstlicher gelenke an knochen.
ES2018092B3 (es) Sabana quirurgica y metodo para su fabricacion.
NO871526D0 (no) Tiolaktam-n-eddiksyrederivater og fremgangsmaate for deres fremstilling.
FI873599A7 (fi) Menetelmä ja seos luuvaurion parantamiseksi.
FR2603797B1 (fr) Implant orbitaire apres enucleation
FI875039A7 (fi) Terapeuttiset koostumukset eläinlääketieteellistä käyttöä varten.
AU7465487A (en) Benzimidazole derivatives and their use as gastric acid secretion inhibitors
NO862898D0 (no) Fremgangsmaate for utvinning av kjoennsprodukter, egnet for kunstig og naturlig befruktning fra pattedyr.
DK310883A (da) Phenyleddikesyrederivater, deres fremstilling og anvendelse
ES2029791T3 (es) Un procedimiento para la preparacion de derivados de pirazina.
AU6826487A (en) Surgery for strengthening tendon in horses leg
FI881465A7 (fi) Halogeeni-pienjännitevalaisin.
EP0175644A3 (en) New pharmaceutical use of somatostatin analogues
ATE47392T1 (de) 4-substituierte 10-cyanmethylen-thieno(4,3-e>benzo-azepine.
ES555473A0 (es) Procedimiento para preparacion de una composicion bacteriana para el tratamiento de afecciones gastrointestinales en animales.
AU7422387A (en) Tumor necrosis factor alpha as treatment for infectious diseases
ES541910A0 (es) Procedimiento para la fabricacion de derivados de 4,7-dihi- dropirazolo (3,4-b)piridina
NO830981L (no) Pentandionsyrederivater og fremgangsmaate for deres fremstilling.
ES1005822Y (es) Arana perfeccionada para lamparas
NO864476D0 (no) Fremgangsmaate for syrebehandling.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 489860

Country of ref document: ES